Found in Translation: Darren Roblyer’s Path From Hands-On Research to Research In-Hand
In order to measure blood pressure noninvasively, it may be prudent to measure how blood flows through the body using light rather than using the standard cuff-based technique. To detect fibrosis in the skin, one may find more luck using advanced optical imaging than relying on the currently used “pinch” scale. And to elevate the field of biophotonics, one may not simply focus on advancing the technologies itself, but the people, outlets, and resources within the research ecosystem. This is the path Dr. Darren Roblyer (BME, ECE) has been carving throughout his career, chasing both common and unsought biomedical engineering opportunities to improve clinical procedures and enhance the field for new and incoming voices.
AIMBE College of Fellows Inducts Three BU ENG Faculty into Class of 2026
Yannis Paschalidis, Shannon Stott, and Darren Roblyer are honored with a distinction reserved for the top two percent of researchers in the biomedical engineering fields.
10 Ways BU Researchers Could Revolutionize Cancer Care
These innovative, potentially lifesaving projects could transform cancer prevention, treatment, and care.
Promotions for ENG Faculty
“They exemplify each day the depth and excellence of Boston University’s talented academic community.”
Using Light to Monitor Blood Pressure and Track Cancer Treatment Progress
Roblyer and his team are testing ways to monitor biological processes—like blood pressure, oxygen levels, and disease progression—with light waves.
Ignition Awards for ENG Researchers
The awards accelerate the advancement of promising new technology, identifying a pathway to bring a new product to market.
Unlocking Insights into Tumors’ Defenses
A BU team has developed a noninvasive method of monitoring the solid stresses within tumors.
Roblyer to Helm New SPIE Journal
Biophotonics Discovery will focus on novel findings in biophotonics research, especially related to basic science and clinical translation.